ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 175 filers reported holding ANTARES PHARMA INC in Q4 2020. The put-call ratio across all filers is 1.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $2,493,000 | +46.3% | 877,667 | +41.7% | 0.22% | +29.8% |
Q2 2020 | $1,704,000 | +27.5% | 619,590 | +9.5% | 0.17% | -1.2% |
Q1 2020 | $1,336,000 | -50.2% | 565,932 | -0.9% | 0.17% | -39.9% |
Q4 2019 | $2,683,000 | +35.8% | 570,810 | -3.3% | 0.29% | +25.2% |
Q3 2019 | $1,975,000 | +205.3% | 590,322 | +200.0% | 0.23% | +219.4% |
Q2 2019 | $647,000 | – | 196,800 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sargent Investment Group, LLC | 3,096,355 | $8,422,000 | 5.18% |
JW Asset Management, LLC | 1,920,524 | $5,224,000 | 3.85% |
Healthcare Value Capital, LLC | 250,000 | $680,000 | 2.64% |
ARMISTICE CAPITAL, LLC | 10,300,000 | $28,016,000 | 2.12% |
Broadfin Capital, LLC | 3,444,147 | $9,368,000 | 1.23% |
PERKINS CAPITAL MANAGEMENT INC | 409,000 | $1,112,000 | 0.86% |
MYCIO WEALTH PARTNERS, LLC | 1,896,500 | $5,158,000 | 0.48% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 1,012,600 | $2,754,000 | 0.22% |
FALCON POINT CAPITAL, LLC | 130,200 | $354,000 | 0.21% |
Brown Advisory Securities, LLC | 275,000 | $781,000 | 0.15% |